The news is directly related to CDW as Morgan Stanley maintains an Overweight rating on the company but lowers the price target. This could indicate a potential decrease in the stock's value in the short term, but the Overweight rating suggests that the company is still expected to outperform the market. Therefore, the impact on the stock price is neutral in the short term.